820960713	820960713	CD	B-NP	O
|	|	NN	I-NP	O
ICH	ICH	NN	I-NP	O
|	|	NN	I-NP	O
08510916	08510916	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2524522	2524522	CD	B-NP	O
|	|	CC	I-NP	O
9/25/2003	9/25/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
labs	lab	NNS	I-NP	O
,	,	,	O	O
ekg	ekg	NN	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/20/2003	11/20/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/13/2003	10/13/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
AHMAU	AHMAU	NN	B-NP	O
,	,	,	O	O
STEVEN	STEVEN	NN	B-NP	O
371-98-02-8	371-98-02-8	CD	I-NP	O
Ba	Ba	NNP	I-NP	O
Room	Room	NNP	I-NP	O
:	:	:	O	O
Lin	Lin	NNP	B-NP	O
En	En	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
5/15/03	5/15/03	CD	B-NP	O
AT	AT	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
echo	echo	NNP	I-NP	O
,	,	,	O	O
BP	BP	NNP	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SCHONES	SCHONES	NNP	B-NP	O
,	,	,	O	O
CESAR	CESAR	NNP	B-NP	O
TRENTON	TRENTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
EC	EC	NNP	B-NP	B-cell_type
ASA	ASA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
GLYBURIDE	GLYBURIDE	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
ZAROXOLYN	ZAROXOLYN	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
METOLAZONE	METOLAZONE	NN	I-NP	B-DNA
-RRB-	-RRB-	HYPH	B-NP	I-DNA
5	5	CD	I-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
QD	QD	NN	I-NP	I-DNA
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	I-DNA
1/150	1/150	CD	I-NP	I-DNA
-LRB-	-LRB-	HYPH	I-NP	I-DNA
0.4	0.4	CD	I-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
-RRB-	-RRB-	HYPH	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
TAB	TAB	NN	I-NP	I-DNA
SL	SL	NN	I-NP	I-DNA
Q5	Q5	NN	I-NP	I-DNA
MIN	MIN	NN	I-NP	I-DNA
X	X	NN	I-NP	I-DNA
3	3	CD	I-NP	I-DNA
PRN	PRN	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
ZOCOR	ZOCOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
6/18	6/18	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

TOPROL	TOPROL	NN	B-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SUST	SUST	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

100	100	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
ACCUPRIL	ACCUPRIL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
QUINAPRIL	QUINAPRIL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/20/03	3/20/03	CD	B-NP	O
by	by	IN	B-PP	O
PHILSON	PHILSON	NN	B-NP	O
,	,	,	O	O
MICHEL	MICHEL	NN	B-NP	O
A.	A.	NN	I-NP	O
,	,	,	O	O
MB	MB	NN	B-NP	B-protein
,	,	,	O	O
BS	BS	NNP	B-NP	O
,	,	,	O	O
PHD	PHD	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
QUINAPRIL	QUINAPRIL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
takes	take	VBZ	B-VP	O
both	both	DT	O	O
Number	Number	NNP	O	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
IMDUR	IMDUR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ISOSORBIDE	ISOSORBIDE	NN	I-NP	O
MONONIT	MONONIT	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	O
SR	SR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
60	60	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
X	X	SYM	B-NP	O
1	1	CD	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
CHCC	CHCC	NNP	B-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/20/03	3/20/03	CD	B-NP	O
by	by	IN	B-PP	O
VIGNEAU	VIGNEAU	NNP	B-NP	O
,	,	,	O	O
FELIPE	FELIPE	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
MB	MB	NN	B-NP	B-protein
,	,	,	O	O
BS	BS	NN	B-NP	B-protein
,	,	,	O	O
PHD	PHD	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ACCUPRIL	ACCUPRIL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
23012272	23012272	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
QUINAPRIL	QUINAPRIL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
takes	take	VBZ	B-VP	O
both	both	CC	O	O
CLOPIDOGREL	CLOPIDOGREL	NN	B-NP	B-protein
75	75	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
START	START	NNP	I-NP	O
THE	THE	NNP	I-NP	O
NEXT	NEXT	NNP	I-NP	O
DAY	DAY	NNP	I-NP	O
NORVASC	NORVASC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
heavy	heavy	JJ	I-NP	O
lifting	lift	VBG	I-NP	O
or	or	CC	I-VP	O
driving	drive	VBG	I-VP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
Lift	Lift	NN	B-NP	O
restrictions	restriction	NNS	I-NP	O
:	:	:	O	O
Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
lift	lift	VB	I-VP	O
greater	great	JJR	B-NP	O
then	then	RB	B-ADVP	O
10	10	CD	B-NP	O
pounds	pound	NNS	I-NP	O
FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
hubert	hubert	VB	B-VP	O
fagle	fagle	JJ	B-NP	O
call	call	NN	I-NP	O
for	for	IN	B-PP	O
apt	apt	JJ	B-NP	O
,	,	,	O	O
No	No	NNP	B-NP	O
Known	Known	NNP	I-NP	O
Allergies	Allergies	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
ischemic	ischemic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	B-protein
Admission	Admission	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
labs	lab	NNS	I-NP	I-protein
,	,	,	O	O
ekg	ekg	NN	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
hypercholesterol	hypercholesterol	NN	B-NP	O
,	,	,	O	O
PVD	PVD	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
cath	cath	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
79	79	CD	B-NP	O
yo	yo	NN	I-NP	O
lady	lady	JJ	I-NP	O
CABG	CABG	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
1991	1991	CD	I-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
and	and	CC	I-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
OM1	OM1	NN	B-NP	B-protein
.	.	.	O	O

Other	Other	JJ	B-NP	O
problems	problem	NNS	I-NP	O
of	of	IN	B-PP	O
HT	HT	NN	B-NP	O
,	,	,	I-NP	O
NIDDM	NIDDM	NN	I-NP	B-protein
and	and	CC	I-NP	O
claudication	claudication	NN	I-NP	O
.	.	.	O	O

Admitted	Admit	VBN	B-VP	O
to	to	TO	B-PP	O
o	o	NN	B-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
ECG	ECG	NN	B-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
small	small	JJ	B-NP	O
enzy	enzy	NN	I-NP	O
,	,	,	O	O
e	e	NN	B-NP	O
rise	rise	NN	I-NP	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
PCH	PCH	NN	B-NP	O
for	for	IN	B-PP	O
cath	cath	NN	B-NP	O
.	.	.	O	O

Angiogram	Angiogram	NNP	B-NP	O
showed	show	VBD	B-VP	O
severe	severe	JJ	B-NP	O
native	native	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
occluded	occlude	VBD	B-VP	O
LAD	LAD	NN	B-NP	O
,	,	,	I-NP	O
OM	OM	NN	I-NP	O
and	and	CC	I-NP	O
RCA	RCA	NN	I-NP	B-protein
.	.	.	O	O

Patent	Patent	NN	B-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
OM2	OM2	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
and	and	CC	O	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
.	.	.	O	O

Left	Leave	VBN	B-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
gradient	gradient	NN	I-NP	O
stented	stente	VBD	B-VP	O
with	with	IN	B-PP	O
6.0	6.0	CD	B-NP	O
x	x	SYM	I-NP	O
18	18	CD	I-NP	O
mm	mm	NN	I-NP	O
omnilink	omnilink	NN	I-NP	O
stent.Groin	stent.Groin	NN	I-NP	O
closed	close	VBD	B-VP	O
with	with	IN	B-PP	O
6F	6F	NN	B-NP	O
pe	pe	NN	I-NP	O
rclose	rclose	NN	I-NP	O
vein	vein	NN	I-NP	O
manually	manually	RB	B-VP	O
compressed	compress	VBN	I-VP	O
.	.	.	O	O

Addendum-pt	Addendum-pt	JJ	B-NP	O
would	would	MD	B-VP	O
get	get	VB	I-VP	O
angina	angina	NN	B-NP	O
when	when	WRB	B-ADVP	O
hypertensive	hypertensive	JJ	B-ADJP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lab	lab	NN	I-NP	B-protein
,	,	,	O	O
so	so	RB	O	O
susupect	susupect	JJ	B-NP	O
small	small	JJ	I-NP	O
vessel	vessel	NN	I-NP	O
disease	disease	NN	I-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
watch	watch	VB	I-VP	O
BP	BP	NN	B-NP	O
given	give	VBN	B-PP	O
renal	renal	JJ	B-NP	O
stenting	stenting	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
if	if	IN	B-SBAR	O
still	still	RB	B-NP	O
hypertensive	hypertensive	JJ	I-NP	O
tomorrow	tomorrow	NN	I-NP	O
PM	PM	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
BP	BP	NN	B-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

Bud	Bud	NNP	B-NP	O
Fasci	Fasci	NNP	I-NP	O
5/8/03	5/8/03	CD	I-NP	O
Overnight	Overnight	NNP	I-NP	O
pt	pt	NN	I-NP	O
developed	develop	VBD	B-VP	O
Cp	Cp	NN	B-NP	B-DNA
with	with	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
and	and	CC	I-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
with	with	IN	B-PP	O
Sl	Sl	NN	B-NP	B-protein
NTG	NTG	NN	I-NP	I-protein
and	and	CC	O	O
IV	IV	CD	B-NP	O
Lopressor.NO	Lopressor.NO	NN	I-NP	O
bump	bump	NN	I-NP	O
in	in	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
.	.	.	O	O

NO	NO	NN	B-NP	B-protein
CP	CP	NN	I-NP	I-protein
since	since	IN	B-PP	O
last	last	JJ	B-NP	O
night	night	NN	I-NP	O
.	.	.	O	O

Started	Started	NNP	B-NP	O
Norvasc	Norvasc	NNP	I-NP	O
5mg	5mg	NN	I-NP	O
and	and	CC	O	O
Imdur	Imdur	NNP	B-NP	O
60mg	60mg	CD	I-NP	O
.	.	.	O	O

Echo	Echo	NN	B-NP	O
today	today	NN	B-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
WMA	WMA	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
continue	continue	VBP	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
today	today	NN	B-NP	O
monitoring	monitoring	NN	I-NP	O
BP	BP	NN	I-NP	O
and	and	CC	O	O
CP	CP	NN	B-NP	B-DNA
Likely	Likely	JJ	I-NP	O
d/c	d/c	NN	I-NP	O
in	in	IN	B-PP	O
am	am	NN	B-NP	O
.	.	.	O	O

8/10/03	8/10/03	CD	B-NP	O
Pt	Pt	NN	I-NP	O
stable	stable	JJ	I-NP	O
today	today	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
and	and	CC	I-NP	O
BP	BP	NN	I-NP	O
well	well	RB	B-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

Ready	Ready	JJ	B-ADJP	O
for	for	IN	B-PP	O
d/c	d/c	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
-	-	HYPH	O	O
you	you	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	B-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
plavix	plavix	NN	B-NP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
3	3	CD	I-NP	O
months	month	NNS	I-NP	O
and	and	CC	O	O
aspirin	aspirin	NN	B-NP	O
for	for	IN	B-PP	O
life	life	NN	B-NP	O
-	-	HYPH	B-NP	O
call	call	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
any	any	DT	B-NP	O
concerns	concern	NNS	I-NP	O
-	-	HYPH	O	O
Call	Call	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Cisnero	Cisnero	NNP	I-NP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
WHEETLEY	WHEETLEY	NNP	B-NP	O
,	,	,	O	O
CHRISTIAN	CHRISTIAN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5/15/03	5/15/03	CD	I-NP	O
@	@	NN	I-NP	O
08	08	CD	I-NP	O
:	:	:	O	O
07	07	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

